GSK5764227 (HS-20093) is a novel antibody-drug conjugate composed of a fully human anti-B7-H3 monoclonal antibody covalently linked to a topoisomerase inhibitor payload.
The researchers also projected that newly diagnosed MM cases will increase by 70.8% by 2045 — from about 188,000 cases in 2022 to about 321,000 cases in 2045. The number of deaths due to MM is ...
A study of more than 3000 physician practices revealed an increase in social risk screening from 2017 to 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback